Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver Resection

NCT03352349 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT03352349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03352349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver Resection
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
December 1, 2017
Completion date
December 30, 2018
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

portal vein pressure